Comparative analysis of the mineral composition of the
leukocyte, erythrocyte fraction and PRP plasma in patients with bisphosphonate osteonecrosis of the jaw bones
Loktionova M.V.1, Zhidovinov A.V.2, Sletova V.A.2, Gabassova I.V.2, Sletov A.A.2,3
1 Department of pediatric, profilactic dentistry and orthodontics, Moscow Medical University named after I.M. Sechenov
2 Stavropol state medical university, Stavropol, Russia
3 Stavropol regional clinical hospital, Россия
E-mail address: firstname.lastname@example.org
A complication of the use of bisphosphonate drugs is the development of bisphosphonate osteonecrosis. There is not enough information about the state of the microelement composition of the blood and the dynamics of metabolic processes for various bisphosphonate drugs. There are 184 patients under observation for bisphosphonate osteonecrosis of the jaw bones. The mineral components of three blood fractions were monitored: sulfur (S2-), chlorine (Cl-), potassium (K+), calcium (Ca2+), phosphorus (P3+) at the preoperative and postoperative stages. At the preoperative stage, the negative dynamics of indicators of bone metabolites (Ca2+ and P3+) contributed to the development of osteomalacia, followed by a jaw fracture due to local loads. Hypercalcemia developed against the background of acidosis in the bone tissue (Ca2+ ions were replaced by H+ ions, with partial diffusion into the liquid fraction, due to disorganization of the synthesis of chondroitinsulfuric acid). Hyperphosphatemia is due to the pharmacokinetics of bisphosphonate drugs. Violation of the metabolism of sulfur-containing amino acids leads to the accumulation of S2- in blood fractions. The decrease in Cl- is due to metabolic acidosis against the background of an atrabiliary gas exchange function of erythrocytes, which enhances the pathological focus of tissues with the migration of Cl- to the lesion. A decrease in K+ was noted against the background of severe muscle atony. The dynamics of the studied parameters correlates with the clinical picture of bisphosphonate osteonecrosis. The trace element composition of blood fractions, starting from the 7th day of the postoperative period, was characterized by a trend towards positive dynamics. With further observation at the 3rd and 6th months, the content of the studied trace elements in the reference values. The clinical picture corresponds to the scope and timing of surgery in 100% of patients.
Keywords: bisphosphonate osteonecrosis; amino acids; oncology of the maxillofacial region;
For citation: Admakin O.I., Loktionova M.V., Zhidovinov
A.V., Sletova V.A., Gabassova I.V., Sletov A.A. Comparative analysis of the mineral composition of the leukocyte, erythrocyte fraction and PRP plasma in patients with bisphosphonate osteonecrosis of the jaw bones. Stomatology for All / Int. Dental Review. 2022, no.3(100): 32-40 (In Russian). doi: 10.35556/idr-2022-3(100)32-40
E-mail address: email@example.com
1. Liu A., Su K.J., Greenbaum J. et al. A transcriptome-wide association study to detect novel genes for volumetric bone mineral density. Bone. 2021, 153: 116106. doi: 10.1016/j.bone.2021.116106
2. Kostyshyn N., Kostyshyn L., Shtablavyi I. Effects of zoledronic acid on bone structure and organization of nanocomposites in rats with glucocorticoid-induced osteoporosis. Biointerface Research in Applied Chemistry.2022. 12(2): 2041—2049. doi: 10.33263/BRIAC122.20412049
3. Tsiskarashvili A.V., Rodionova S.S., Mironov S.P. et al. Metabolic bone tissue disorders in patients with long bone fractures complicated by chronic osteomyelitis. Orthopaedic Genius. 2019, 25(2): 149—155. doi:10.18019/1028-4427-2019-25-2-149-155
4. Anikin S.G., Toroptsova N.V. Bisphosphonates: what we know about the undesirable phenomena associated with their use. Pharmateca. 2012, no.19(252): 81—87 (In Russian).
5. Arkhangelskaya O.P., Tolstunov L.G. Osteonecrosis of the facial skull: clinic, diagnosis, treatment. General Practitioner’s Handbook. 2021, no.5: 28—35 (In Russian). doi: 10.33920/med-10-2105-03
6. Ermolaev M.V. Biological chemistry. Textbook for students of medical schools. Moscow: Medicine, 1974, 264 p. (In Russian).
7. Khodorovich N.A., Bilibin D.P., Shevelev O.A., Churyukanov V.V. Changes in the trace element composition of blood in aseptic inflammation on the background of hypoxia. Journal of scientific articles Health and Education in the XXI century. 2012, 14(3): 299 (In Russian).
8. Kadyrova L.R., Bashkova I.B., Akarachkova E.S. Approaches to the diagnosis and treatment of primary osteoarthritis (to help a practicing doctor). Russian Medical Journal. Medical review. 2021, 5(5): 288—293 (In Russian). doi:10.32364/2587-6821-2021-5-5-288-293
9. Helminskaya N.M., Magomedov M.M., Goncharova A.V. et al. Experience of an interdisciplinary approach to the diagnosis and treatment of patients with bisphosphonate osteonecrosis of the upper jaw. Bulletin of Otorhinolaryngology. 2019, 84(5): 44—47 (In Russian). doi: 10.17116/otorino20198405144
10. Esin V.A., Kudryashova E.A., Davydova O.B., Belov D.I. Features of management of patients with bisphosphate osteonecrosis of the jaws. Youth and medical science:Abstracts of the VIII All-Russian Interuniversity Scientific and Practical Conference of Young Scientists with International participation, Tver, November 26, 2020. Tver: Tver State Medical Academy of the Ministry of Health of the Russian Federation, 2020: 32 (In Russian).
11. Shchetinin E.V., Sirak S.V., Petrosyan G.G. et al. Evaluation of the mechanisms of bone mineralization in various stages of reparative osteogenesis in the conditions of medicinal ultraphonophoresis. Medical Bulletin of the North Caucasus. 2019, 14(1—2): 260—264 (In Russian). doi:10.14300/mnnc.2019.14029
12. Sletov A.A., Sirak S.V., Shchetinin E.V. et al. A device for optimizing the biomechanics of the mandible with a
subtotal defect. Patent No. 2680025 C1. Russian Federation, IPC A61B 17/64, A61C 8/00.: No. 2017137180: application 23.10.2017: publ. 14.02.2019; applicant Federal State Budgetary Educational Institution of Higher Education Stavropol State Medical University (Stavropol State Medical University) Ministry of Health of the Russian Federation (In Russian).
13. Tolstikova E.A., Tolstikov N.A., Sletov A.A. Monitoring of biochemical parameters in patients with defects in the tissues of the maxillofacial region after administration of therapeutic doses of bisphosphonate preparations. Humanitarian and biomedical education: problems, prospects, integration, Stavropol, October 22, 2021. Stavropol: Stavropol State Medical University, 2021: 263— 264 (In Russian).
14. Kobets E.V., Alekna V., Rudenko E.V. and others. Pharmacogenetic aspects of antiresorptive therapy of postmenopausal osteoporosis with bisphosphonates.
Molecular and applied genetics. 2020, 29: 49—58 (In Russian).
15. Voloznev L.V., Klementyeva O.E., Korsunsky V.N., Lysenko N.P. Experimental evaluation of functional suitability of radiopharmaceutical preparation 188 Re-zoledronic acid. Molecular medicine. 2013, no.2: 42—45 (In Russian).